Gómez-Almaguer, David <br/><br/>
Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults.  [electronic resource] 

 -  Blood  Jun 2014 
 - 3906-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2014-01-549360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents--administration & dosage<br/>Benzoates--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydrazines--administration & dosage<br/>Male<br/>Middle Aged<br/>Platelet Count<br/>Purpura, Thrombocytopenic, Idiopathic--drug therapy<br/>Pyrazoles--administration & dosage<br/>Receptors, Thrombopoietin--agonists<br/>Time Factors<br/>Treatment Outcome